Anbio Biotechnology (NNNN) P/E (2025 - 2026)
Anbio Biotechnology (NNNN) P/E from Feb 19, 2025 to Jul 21, 2026. The TTM Anbio Biotechnology (NNNN) P/E is 64.96. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Anbio Biotechnology (NNNN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 64.96 | -68.34% |
| 2025 | 205.19 | N/A |
Comparison Anbio Biotechnology (NNNN) P/E with competitors
Anbio Biotechnology (NNNN) P/E is 64.96.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| MHUA | Meihua International Medical Technologies Co Ltd - Class A | 0.22 | -99.66% |
| EMBC | Embecta Corp | 1.69 | -97.40% |
| SOLV | Solventum Corp | 9.49 | -85.39% |
| ZJYL | Jin Medical International Ltd | 12.75 | -80.38% |
| PDEX | Pro-Dex Inc (co) | 15.22 | -76.57% |
| RMD | Resmed Inc | 19.04 | -70.68% |
| UTMD | Utah Medical Products Inc | 20.76 | -68.04% |
| ATR | Aptargroup Inc | 21.65 | -66.68% |
| ALGN | Align Technology Inc | 30.29 | -53.37% |
| HOLX | Hologic Inc | 30.86 | -52.49% |
| MMSI | Merit Medical Systems Inc | 31.15 | -52.06% |
| STVN | Stevanato Group Spa | 31.25 | -51.89% |
| LMAT | Lemaitre Vascular Inc | 36.34 | -44.06% |
| ALC | Alcon Inc | 41.51 | -36.09% |
| ISRG | Intuitive Surgical Inc | 46.43 | -28.53% |
| BDX | Becton Dickinson & Company | 46.93 | -27.76% |
| WST | West Pharmaceutical Services Inc | 47.41 | -27.02% |
| NEPH | Nephros Inc | 50.00 | -23.04% |
| COO | Cooper Companies Inc | 58.98 | -9.21% |
| NVST | Envista Holdings Corp | 64.66 | -0.46% |
| BAX | Baxter International Inc | 72.66 | +11.84% |
| ICUI | ICU Medical Inc | 84.82 | +30.57% |
| RGEN | Repligen Corp | 162.20 | +149.68% |
| WRBY | Warby Parker Inc - Class A | 318.30 | +389.97% |